The decreased sleep efficiency and the increased sleep fragmentation beside the SAS causes activation of the hypothlamo-pituitary-adrenal axis leading to increased sympathetic overactivity, oxidative stress, and increased systemic inflammation which in turn result in metabolic dysfunction and higher insulin resistance. This evidence concerns the gene INS and SATB2 associated disorder.